Soleno Therapeutics (6XC.MU) Q1 2026 Earnings

25FebConfirmed
Q1 2026
0.6
0.63
0.65
0.68

Details

Expected EPS
0.60162331236
Actual EPS
0.677152
Surprise EPS
0.08
Surprise Percent
+12.55%

Description

Soleno Therapeutics (6XC.MU) has reported earnings of 0.677152 per share for Q1 2026.

0 Comments

Share your thoughts